Cohort Study: In Patients with Rectal Cancer, Restriction of Neoadjuvant Chemoradiotherapy to High‐Risk Patients Achieved Good Results
29 Jun, 2018 | 03:10h | UTCOncological outcome after MRI‐based selection for neoadjuvant chemoradiotherapy in the OCUM Rectal Cancer Trial – British Journal of Surgery (link to abstract – $ for full-text)
Commentaries: Many patients with rectal cancer may not need chemoradiotherapy – eCancer News (free) AND Limiting Chemo to High-Risk Rectal Cancer Called Feasible – MedPage Today (free registration required) AND OCUM Trial: Some Rectal Cancers Need Only Surgery – Medscape (free registration required)